EA200901499A1 - Способ введения легочного сурфактанта - Google Patents

Способ введения легочного сурфактанта

Info

Publication number
EA200901499A1
EA200901499A1 EA200901499A EA200901499A EA200901499A1 EA 200901499 A1 EA200901499 A1 EA 200901499A1 EA 200901499 A EA200901499 A EA 200901499A EA 200901499 A EA200901499 A EA 200901499A EA 200901499 A1 EA200901499 A1 EA 200901499A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pulmonary surfactant
introduction
infant
treatment
need
Prior art date
Application number
EA200901499A
Other languages
English (en)
Other versions
EA016308B1 (ru
Inventor
Эгберт Хертинг
Вольфганг Гопель
Паоло Кьези
Original Assignee
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. filed Critical КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Publication of EA200901499A1 publication Critical patent/EA200901499A1/ru
Publication of EA016308B1 publication Critical patent/EA016308B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Данное изобретение относится к способу лечения респираторного дистресс-синдрома у младенца, нуждающегося в таком лечении, включающему интратрахеальное введение легочного сурфактанта посредством тонкой трубки.
EA200901499A 2007-06-08 2008-05-23 Набор для предупреждения и/или лечения респираторного дистресс-синдрома EA016308B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/811,351 US8048043B2 (en) 2007-06-08 2007-06-08 Method of administration of a pulmonary surfactant
PCT/EP2008/004120 WO2008148469A1 (en) 2007-06-08 2008-05-23 A method of administration of a pulmonary surfactant

Publications (2)

Publication Number Publication Date
EA200901499A1 true EA200901499A1 (ru) 2010-06-30
EA016308B1 EA016308B1 (ru) 2012-04-30

Family

ID=39832595

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200901499A EA016308B1 (ru) 2007-06-08 2008-05-23 Набор для предупреждения и/или лечения респираторного дистресс-синдрома

Country Status (23)

Country Link
US (2) US8048043B2 (ru)
EP (2) EP2164504B1 (ru)
JP (1) JP5490683B2 (ru)
KR (2) KR101344159B1 (ru)
CN (1) CN101765431B (ru)
AU (1) AU2008258872B2 (ru)
BR (1) BRPI0811387B8 (ru)
CA (1) CA2690097C (ru)
CY (2) CY1116680T1 (ru)
DK (2) DK2164504T3 (ru)
EA (1) EA016308B1 (ru)
ES (2) ES2547489T3 (ru)
HK (1) HK1141457A1 (ru)
HR (2) HRP20150966T1 (ru)
HU (2) HUE025957T2 (ru)
LT (1) LT2719391T (ru)
ME (1) ME02327B (ru)
MX (2) MX359316B (ru)
PL (2) PL2164504T3 (ru)
PT (2) PT2719391T (ru)
RS (2) RS54196B1 (ru)
SI (2) SI2164504T1 (ru)
WO (1) WO2008148469A1 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2475373B1 (en) * 2009-09-08 2013-11-13 Chiesi Farmaceutici S.p.A. A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
RU2504395C1 (ru) * 2012-07-13 2014-01-20 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ/ФГБУ "РНЦРХТ" Минздравсоцразвития России Способ профилактики бронхолегочной дисплазии у новорожденных с очень низкой и экстремально низкой массой тела при рождении
ITMI20150033U1 (it) * 2015-02-13 2016-08-13 Chiesi Farm Spa Catetere per la somministrazione di un surfattante polmonare
EP3277351B1 (en) 2015-04-02 2019-06-05 Hill-Rom Services PTE. LTD. Manifold for respiratory device
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
WO2016174269A1 (en) * 2015-04-30 2016-11-03 University Of Bremen A novel skin medical and cosmetic care product
EP3490649A1 (en) 2016-07-28 2019-06-05 Chiesi Farmaceutici S.p.A. Method and system for delivery of an aerosolized medicament
MA46605A (fr) 2016-10-26 2021-06-02 Chiesi Farm Spa Dispositif permettant de faciliter l'administration d'un médicament aux poumons par l'intermédiaire d'un cathéter
JP2020502242A (ja) 2016-12-22 2020-01-23 キエージ・フアルマチエウテイチ・エツセ・ピ・ア 進行性のｂｐｄの処置のための肺サーファクタント及びステロイドを含む処置的組み合わせ物
AU2019260526A1 (en) 2018-04-23 2020-11-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD
MA54367A (fr) 2018-12-06 2021-11-10 Chiesi Farm Spa Dispositif de contrôle des voies aériennes à masque laryngé et procédé d'administration d'un médicament à travers un dispositif de contrôle des voies aériennes à masque laryngé
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
AU2022306466A1 (en) * 2021-07-05 2024-02-15 Chiesi Farmaceutici S.P.A. Process for the preparation of a pulmonary surfactant
CN115634199B (zh) * 2022-10-18 2024-05-03 杭州汉库医药科技有限公司 一种混悬型肺表面活性物质注射液及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
GB9524007D0 (en) * 1995-11-23 1996-01-24 Bangham Alec D Endotrachael tubes with pulmonary medicaments
IT1308180B1 (it) 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
WO2003035679A2 (en) * 2001-10-25 2003-05-01 Medical Research Council Molecules
EP1897577B1 (de) * 2002-08-02 2012-05-16 Med In Medical Innovations GmbH Vorrichtung zur Erzeugung eines kontinuierlichen positiven Atemwegdrucks (CPAP-Vorrichtung)
US20060040860A1 (en) * 2004-06-17 2006-02-23 Mario Ruediger Intra-tracheal application of vascular endothelial growth factor (VEGF) for the prevention of lung damages caused by hperoxia
US20060112961A1 (en) * 2004-11-29 2006-06-01 Hany Aly Pediatric mask, especially suited for premature infants
ES2380046T3 (es) * 2005-01-06 2012-05-08 Discovery Laboratories, Inc. Régimen para el tratamiento con tensioactivos para tratar o prevenir la displasia broncopulmonar

Also Published As

Publication number Publication date
EP2719391B1 (en) 2016-11-30
US20120017896A1 (en) 2012-01-26
KR101399738B1 (ko) 2014-05-27
AU2008258872B2 (en) 2012-10-04
KR101344159B1 (ko) 2013-12-23
HK1141457A1 (en) 2010-11-12
CN101765431B (zh) 2013-04-03
HRP20170270T1 (hr) 2017-04-21
KR20100028530A (ko) 2010-03-12
RS55733B1 (sr) 2017-07-31
US8905979B2 (en) 2014-12-09
US20080305180A1 (en) 2008-12-11
PL2719391T3 (pl) 2017-06-30
EP2164504A1 (en) 2010-03-24
MX359316B (es) 2018-09-25
RS54196B1 (en) 2015-12-31
CA2690097C (en) 2018-05-22
JP2010528729A (ja) 2010-08-26
BRPI0811387B8 (pt) 2021-05-25
EA016308B1 (ru) 2012-04-30
KR20130038940A (ko) 2013-04-18
ES2616727T3 (es) 2017-06-14
SI2164504T1 (sl) 2015-10-30
ME02327B (me) 2016-06-20
PT2164504E (pt) 2015-10-16
DK2164504T3 (en) 2015-10-12
HRP20150966T1 (hr) 2015-10-09
WO2008148469A1 (en) 2008-12-11
BRPI0811387A2 (pt) 2015-07-21
CA2690097A1 (en) 2008-12-11
HUE031750T2 (en) 2017-07-28
BRPI0811387B1 (pt) 2018-11-06
PT2719391T (pt) 2017-03-02
AU2008258872A1 (en) 2008-12-11
PL2164504T3 (pl) 2016-01-29
DK2719391T3 (en) 2017-02-20
SI2719391T1 (sl) 2017-03-31
JP5490683B2 (ja) 2014-05-14
MX2009012835A (es) 2009-12-15
US8048043B2 (en) 2011-11-01
ES2547489T3 (es) 2015-10-06
CN101765431A (zh) 2010-06-30
HUE025957T2 (en) 2016-05-30
EP2164504B1 (en) 2015-07-29
CY1116680T1 (el) 2017-03-15
CY1118635T1 (el) 2017-07-12
EP2719391A1 (en) 2014-04-16
LT2719391T (lt) 2017-02-10

Similar Documents

Publication Publication Date Title
EA200901499A1 (ru) Способ введения легочного сурфактанта
CY1123208T1 (el) Κυκλικα παραγωγα εστερων βορονικου οξεος, μεθοδος για την παρασκευη και θεραπευτικες χρησεις αυτων
EA201270616A1 (ru) Ингибиторы вируса гепатита с
CL2012000643A1 (es) Metodo para reducir la emision de oxido nitroso del suelo porque comprende tratar una planta con inhibidores de la respiracion
PE20160841A1 (es) Macrociclos como inhibidores del factor de coagulacion (fxia)
CY1112495T1 (el) Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης
EA201071315A1 (ru) Ингибиторы протеазы вируса гепатита с
MA32467B1 (fr) Derives de piperidinyle agonistes de gpcr
UA113651C2 (xx) Макроциклічні пурини для лікування вірусних інфекцій
MX347596B (es) Derivados de purina para el tratamiento de infecciones viricas.
EA024630B9 (ru) Производные пиразола как ингибиторы ионных каналов, активируемых высвобождением кальция (crac)
CY1122805T1 (el) Ενωσεις και μεθοδοι για την αγωγη βακτηριακων λοιμωξεων
EA201171367A1 (ru) Винилиндазолильные соединения
CY1115381T1 (el) Διενυδρη υδροχλωρικη ναλμεφαινη
EA201200977A1 (ru) Лечение синдрома ли и ли-подобного синдрома токотриенолхинонами
PL412787A1 (pl) Oparty na makrofagach celowany system dostarczania związków związanych z ferrytyną
EA201490590A1 (ru) Способы лечения внутрилегочных инфекций
EA201491286A1 (ru) Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину
CY1123438T1 (el) Διαδικασια για παραγωγη και καθαρισμοανασυνδυασμενης λυσοσωμικης αλφα-μαννοσιδασης
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
CR20130610A (es) Método de tratamiento de la fiebre dengue
CY1120487T1 (el) Νεα μεθοδος για τη θεραπεια λοιμωξεων απο ελικοβακτηριδιο του πυλωρου (η. pylori)
MX2019013468A (es) Metodos para tratar la enfermedad pulmonar obstructiva cronica usando benralizumab.
CY1118067T1 (el) Μεθοδος για τη ληψη ενος τριπλοειδους διαειδικου υβριδιου απο μυλοκοπι και στικτομυλοκοπι
DK2247573T3 (da) Kulsyre- og svovlsyresalte af 3-(2,2,2-trimethylhydrazinium)propionatstere af anvendelse deraf til fremstilling og 3-(2,2,2-trimethylhydrazinium)propionat-dihydrat

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM